InsiderClue
Stocks · Health care · Electromedical & Electrotherapeutic Apparatus

TransMedics Group, Inc.

TMDX Clue Score84
United States Fiscal year ends December CIK 0001756262
$77.87 -1.43% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $77.87 +191.10% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 2 May 2019. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Fiscal year 2018Revenue14.7Operating income−20.2Net income−23.8Fiscal year 2019Revenue25.8 +76.3%Operating income−29.6Net income−33.5Fiscal year 2020Revenue25.6 −0.8%Operating income−26.4Net income−28.7EPS, diluted−1.16Fiscal year 2021Revenue31.4 +22.4%Operating income−39.4Net income−44.2EPS, diluted−1.60Fiscal year 2022Revenue93.5 +197.8%Operating income−31.4Net income−36.2EPS, diluted−1.23Fiscal year 2023Revenue241.6 +158.5%Operating income−28.7Net income−25.0EPS, diluted−0.77Fiscal year 2024Revenue441.5 +82.7%Operating income37.5Net income35.5EPS, diluted1.01Fiscal year 2025Revenue605.5 +37.1%Operating income108.6Net income190.3 +436.6%EPS, diluted4.87 +382.2%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a 14.7 25.8 25.6 31.4 93.5 241.6 441.5 605.5
Growth +76.3% −0.8% +22.4% +197.8% +158.5% +82.7% +37.1%
Operating income n/a −20.2 −29.6 −26.4 −39.4 −31.4 −28.7 37.5 108.6
Net income n/a −23.8 −33.5 −28.7 −44.2 −36.2 −25.0 35.5 190.3
Growth +436.6%
EPS, diluted n/a n/a n/a −1.16 −1.60 −1.23 −0.77 1.01 4.87
Growth +382.2%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2017Fiscal year 2018Gross margin39.1%Operating margin−138.1%Net margin−162.1%Free cash flow margin−180.1%Fiscal year 2019Gross margin53.6%Operating margin−114.5%Net margin−129.8%Free cash flow margin−125.6%Fiscal year 2020Gross margin64.9%Operating margin−102.9%Net margin−112.1%Free cash flow margin−119.8%Fiscal year 2021Gross margin67.4%Operating margin−125.6%Net margin−140.9%Free cash flow margin−103.2%Fiscal year 2022Gross margin69.8%Operating margin−33.6%Net margin−38.8%Free cash flow margin−61.8%Fiscal year 2023Gross margin63.8%Operating margin−11.9%Net margin−10.4%Free cash flow margin−68.2%Fiscal year 2024Gross margin59.4%Operating margin8.5%Net margin8.0%Free cash flow margin−18.3%Fiscal year 2025Gross margin59.9%Operating margin17.9%Net margin31.4%Free cash flow margin22.1%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin n/a 39.1% 53.6% 64.9% 67.4% 69.8% 63.8% 59.4% 59.9%
Operating margin n/a −138.1% −114.5% −102.9% −125.6% −33.6% −11.9% 8.5% 17.9%
Net margin n/a −162.1% −129.8% −112.1% −140.9% −38.8% −10.4% 8.0% 31.4%
Free cash flow margin n/a −180.1% −125.6% −119.8% −103.2% −61.8% −68.2% −18.3% 22.1%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Fiscal year 2018Operating cash flow−26.0Capital expenditure−0.4Free cash flow−26.4Fiscal year 2019Operating cash flow−32.3Capital expenditure−0.2Free cash flow−32.5Fiscal year 2020Operating cash flow−30.3Capital expenditure−0.5Free cash flow−30.7Fiscal year 2021Operating cash flow−28.9Capital expenditure−3.5Free cash flow−32.4Fiscal year 2022Operating cash flow−45.8Capital expenditure−11.9Free cash flow−57.7Fiscal year 2023Operating cash flow−13.0Capital expenditure−151.8Free cash flow−164.9Fiscal year 2024Operating cash flow48.8Capital expenditure−129.7Free cash flow−80.9Fiscal year 2025Operating cash flow192.8Capital expenditure−59.3Free cash flow133.6
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow n/a −26.0 −32.3 −30.3 −28.9 −45.8 −13.0 48.8 192.8
Capital expenditure n/a −0.4 −0.2 −0.5 −3.5 −11.9 −151.8 −129.7 −59.3
Free cash flow n/a −26.4 −32.5 −30.7 −32.4 −57.7 −164.9 −80.9 133.6
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2017Cash12.4Shareholders’ equity−168.7Fiscal year 2018Cash20.2Total debt33.7Net cash (debt)−13.4Shareholders’ equity−192.2Fiscal year 2019Cash20.1Total debt34.1Net cash (debt)−14.1Shareholders’ equity54.6Debt to equity0.62Fiscal year 2020Cash24.6Total debt34.7Net cash (debt)−10.1Shareholders’ equity103.9Debt to equity0.33Fiscal year 2021Cash25.6Total debt35.2Net cash (debt)−9.6Shareholders’ equity67.9Debt to equity0.52Fiscal year 2022Cash201.2Total debt58.7Net cash (debt)142.5Shareholders’ equity187.4Debt to equity0.31Fiscal year 2023Cash394.8Shareholders’ equity137.2Fiscal year 2024Cash337.2Shareholders’ equity228.6Fiscal year 2025Cash488.9Total debt10.0Net cash (debt)478.9Shareholders’ equity473.1Debt to equity0.02
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 12.4 20.2 20.1 24.6 25.6 201.2 394.8 337.2 488.9
Total debt n/a 33.7 34.1 34.7 35.2 58.7 n/a n/a 10.0
Net cash (debt) n/a −13.4 −14.1 −10.1 −9.6 142.5 n/a n/a 478.9
Shareholders’ equity −168.7 −192.2 54.6 103.9 67.9 187.4 137.2 228.6 473.1
Debt to equity n/a n/a 0.62 0.33 0.52 0.31 n/a n/a 0.02

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 30 Dec 2017 FY2018 29 Dec 2018 FY2019 28 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
n/a 14.7 25.8 25.6 31.4 93.5 241.6 441.5 605.5
Growth +76.3% −0.8% +22.4% +197.8% +158.5% +82.7% +37.1%
n/a 7.3 9.7 9.0 9.1 28.2 87.5 179.5 242.7
n/a 5.7 13.9 16.6 21.2 65.3 154.1 262.1 362.8
Growth +141.8% +20.0% +27.2% +208.5% +136.1% +70.1% +38.4%
n/a 13.7 19.9 18.8 22.3 26.8 36.1 56.0 69.1
n/a 12.3 23.6 24.2 38.3 69.9 119.6 168.6 185.2
n/a −20.2 −29.6 −26.4 −39.4 −31.4 −28.7 37.5 108.6
Growth +189.6%
n/a −23.7 −33.5 −28.7 −44.2 −36.2 −26.7 35.8 107.5
0.0 0.0 0.0 0.0 n/a 0.1 −1.6 0.3 −82.8
n/a −23.8 −33.5 −28.7 −44.2 −36.2 −25.0 35.5 190.3
Growth +436.6%
Per share
n/a n/a n/a −1.16 −1.60 −1.23 −0.77 1.07 5.60
n/a n/a n/a −1.16 −1.60 −1.23 −0.77 1.01 4.87
Growth +382.2%
n/a n/a n/a 24.7 27.6 29.6 32.5 33.2 34.0
n/a n/a n/a 24.7 27.6 29.6 32.5 35.2 40.5
Growth +11.8% +7.0% +10.0% +8.3% +15.1%

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 88.2% a year over five years.
  • The diluted share count rose 64.1% in five years, which is dilution.
  • Operating margin is up 120.8 points on five years ago, at 17.9%.
  • A net loss in 6 of 8 years on file.